Applied Historical Income Statement
| APDN Stock | USD 0.15 0.01 6.25% |
Historical analysis of Applied DNA income statement accounts such as Other Operating Expenses of 14 M, Total Operating Expenses of 12.7 M or Depreciation And Amortization of 1 M can show how well Applied DNA Sciences performed in making a profits. Evaluating Applied DNA income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Applied DNA's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Applied DNA Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Applied DNA Sciences is a good buy for the upcoming year.
Applied |
About Applied Income Statement Analysis
Applied DNA Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Applied DNA shareholders. The income statement also shows Applied investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Applied DNA Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Applied DNA Sciences. It is also known as Applied DNA overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Most accounts from Applied DNA's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Applied DNA Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. At this time, Applied DNA's Minority Interest is very stable compared to the past year. As of the 29th of November 2024, Net Interest Income is likely to grow to about 91 K, while Other Operating Expenses is likely to drop about 14 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 18.2M | 13.4M | 15.4M | 16.1M | Research Development | 3.9M | 3.7M | 4.3M | 4.5M |
Applied DNA income statement Correlations
Click cells to compare fundamentals
Applied DNA Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied DNA income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 162.4K | 115.8K | 2.0M | 13.2M | 15.2M | 16.0M | |
| Other Operating Expenses | 14.5M | 21.3M | 32.1M | 24.3M | 28.0M | 14.0M | |
| Operating Income | (12.5M) | (12.3M) | (14.0M) | (11.0M) | (9.9M) | (10.4M) | |
| Ebit | (12.5M) | (12.5M) | (14.0M) | (11.0M) | (9.9M) | (10.4M) | |
| Ebitda | (12.2M) | (11.7M) | (12.7M) | (9.6M) | (8.6M) | (9.1M) | |
| Total Operating Expenses | 13.7M | 17.2M | 19.0M | 16.5M | 19.0M | 12.7M | |
| Income Before Tax | (13.0M) | (14.3M) | (8.3M) | (10.0M) | (9.0M) | (9.5M) | |
| Net Income | (12.8M) | (16.0M) | (8.4M) | (9.9M) | (9.0M) | (9.4M) | |
| Depreciation And Amortization | 285.7K | 844.4K | 1.3M | 1.4M | 1.2M | 1.0M | |
| Total Other Income Expense Net | (493.9K) | (1.8M) | 5.7M | 930.4K | 837.3K | 879.2K | |
| Income Tax Expense | (263.9K) | 1.8M | 107.9K | (75.9K) | (87.2K) | (82.9K) | |
| Selling General Administrative | 10.1M | 12.6M | 15.1M | 12.8M | 11.5M | 10.0M | |
| Research Development | 3.3M | 3.8M | 3.9M | 3.7M | 4.3M | 4.5M | |
| Total Revenue | 1.9M | 9.0M | 18.2M | 13.4M | 15.4M | 16.1M | |
| Gross Profit | 1.2M | 4.9M | 5.1M | 5.5M | 6.4M | 6.7M | |
| Cost Of Revenue | 720.9K | 4.1M | 13.1M | 7.8M | 9.0M | 9.5M | |
| Net Income From Continuing Ops | (13.0M) | (14.3M) | (8.3M) | (10.0M) | (11.5M) | (12.1M) | |
| Net Income Applicable To Common Shares | (8.9M) | (13.0M) | (14.3M) | (8.4M) | (9.6M) | (10.1M) | |
| Minority Interest | (1.7K) | (8.0K) | 2.2K | 75.9K | 87.2K | 91.6K | |
| Net Interest Income | (115.8K) | 13.7K | 7.2K | 75.3K | 86.6K | 91.0K | |
| Reconciled Depreciation | 285.7K | 844.4K | 1.3M | 1.4M | 1.6M | 841.4K |
Pair Trading with Applied DNA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.Moving against Applied Stock
| 0.86 | GLW | Corning Incorporated | PairCorr |
| 0.86 | JBL | Jabil Circuit | PairCorr |
| 0.8 | ZBRA | Zebra Technologies | PairCorr |
| 0.73 | FLEX | Flex | PairCorr |
| 0.73 | MYNA | Mynaric AG ADR | PairCorr |
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.50) | Revenue Per Share 2.202 | Quarterly Revenue Growth (0.73) | Return On Assets (0.57) | Return On Equity (0.76) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.